pharmacologic therapy
Jump to navigation
Jump to search
Introduction
Organizational use of pharmaceuticals[2]
More general terms
More specific terms
- antibiotic therapy
- anticoagulation
- biotherapy (immunotherapy)
- chelation therapy
- chemotherapy
- dual antiplatelet therapy (DAPT)
- glucocorticoid trial
- high-dose insulin euglycemia therapy
- high-intensity statin therapy
- hormonal therapy
- inhalation therapy
- intrathecal/epidural administration
- iron replacement therapy
- long-term pharmacologic therapy
- mineral supplementation (mineral deficiency prevention)
- off label use
- pharmacotherapy via nephrostomy
- prednisone for rheumatoid arthritis
- pulse therapy
- remote-controlled drug delivery
- topical therapy
- two or more anti-hypertensive agents prescribed
- underdosing of drug
- vitamin supplementation
Additional terms
References
- ↑ World Health Organization (WHO) WHO updates Essential Medicines List with new advice on use of antibiotics, and adds medicines for hepatitis C, HIV, tuberculosis and cancer. WHO News Release. June 6, 2017 http://www.who.int/mediacentre/news/releases/2017/essential-medicines-list/en/
WHO Model List of Essential Medicines. March 2017 http://www.who.int/medicines/publications/essentialmedicines/20th_EML2017.pdf
WHO Model List of Essential Medicines for Children. March 2017 http://www.who.int/medicines/publications/essentialmedicines/6th_EMLc2017.pdf = World Health Organization Model List of Essential Medicines. 21st List. 2019 https://apps.who.int/iris/bitstream/handle/10665/325771/WHO-MVP-EMP-IAU-2019.06-eng.pdf - ↑ 2.0 2.1 Khot U, Militello M, Vogan E. Navigating Pharmaceutical Price Increases: A Strategy to Protect Appropriate Use, Reduce Waste, and Identify Therapeutic Alternatives. NEJM Catalyst. Cleveland Clinic Case Study. Sept 7, 2017 http://catalyst.nejm.org/navigating-pharmaceutical-price-increases-cleveland-clinic-strategy/